Myeloproliferative neoplasms trials in Russia
3 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 4RecruitingTrial-stage medicine
Asciminib Roll-over Study
- Where
- Moscow, Saint Petersburg
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522EU 2023-507557-16-00Registry updated 2026-11-09
Phase 2RecruitingTrial-stage medicine
Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen
- Where
- Saint Petersburg
- Age
- 18 years to 75 years
- People
- 88
- Run by
- St. Petersburg State Pavlov Medical University
See details and how to joinNCT06532084Registry updated 2024-08-01
Phase 2RecruitingTrial-stage medicine
BeFluBu vs FluBuRux Conditioning in Haploidentical HCT
- Where
- Saint Petersburg
- Age
- 18 years to 75 years
- People
- 220
- Run by
- St. Petersburg State Pavlov Medical University
See details and how to joinNCT06477549Registry updated 2024-06-27
All Myeloproliferative neoplasms trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.